Loading clinical trials...
Loading clinical trials...
A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT CTN Protocol #0801)
Conditions
Interventions
Sirolimus + calcineurin inhibitor + prednisone
Sirolimus + prednisone
Locations
31
United States
City of Hope National Medical Center
Duarte, California, United States
University of California San Diego Medical Center
La Jolla, California, United States
Stanford Hospital and Clinics
Stanford, California, United States
University of Florida College of Medicine (Shands)
Gainesville, Florida, United States
Emory University
Atlanta, Georgia, United States
Blood & Marrow Transplant Program at Northside Hospital
Atlanta, Georgia, United States
Start Date
April 1, 2010
Primary Completion Date
February 14, 2017
Completion Date
June 1, 2018
Last Updated
December 5, 2018
NCT02611180
NCT04294641
NCT05502783
NCT05509582
NCT04146207
NCT02519816
Lead Sponsor
Medical College of Wisconsin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions